The Forhair clinic is excited to announce the launch of Tricopat, a cutting-edge solution for hair loss treatment. Tricopat leverages iontophoresis technology to effectively deliver products and medications deep into the scalp. This innovative approach was introduced to the United States by Dr. Cole in February 2024, marking a significant advancement in regenerative therapy for hair loss. The Tricopat uses a combination of microdermabrasion, pressure wave stimulation, photostimulation, and iontophoresis to deliver products and medications into the scalp. The Tricopat is a patented product from the University of Bologna in Italy.
How Does Tricopat Promotes Hair Growth?
Tricopat employs a unique two-step process for product delivery: initial skin patting to boost circulation followed by the iontophoretic delivery of charged molecules. The device comes with a proprietary blend of growth factors and amino acids, enhancing treatment efficacy. Tricopat allows for the painless delivery of key hair growth agents such as dutasteride, finasteride, minoxidil, latanoprost, and exosomes without the need for local anesthesia or injections, making it a needle-free solution. Opting for additional medications or exosomes with the Tricopat treatment incurs a modest price increase, offering customizable treatment options to meet individual needs efficiently.
What are the Benefits of Tricopat?
One of the key advantages of Tricopat is its affordability. Priced at just $350.00 per treatment, this energy delivery device offers a cost-effective option for patients seeking regenerative solutions for their hair loss.
What is Iontophoresis?
Iontophoresis is a technique used to enhance the penetration of drugs or other products through the skin by applying a low electrical current. This method is commonly used in dermatology and physical therapy for the delivery of medications and other agents directly into the skin or deeper tissues. Here’s how it works:
Overall, iontophoresis is a valuable technique for enhancing the delivery of drugs and other products into the skin, leveraging electrical currents to overcome the natural barriers presented by the skin’s outer layers.
The Tricopat Workflow
The handpiece’s 5 dual-coned protuberances tension the skin, allowing the upper cone to penetrate the epidermis without damaging the underlying membrane. This micro-hammering action induces microtraumas, prompting dermal cells to self-repair, thus boosting collagen and elastin production, enhancing the skin’s structural components without replacing them. The device generates a radial acoustic wave that initiates three different mechanisms in a single treatment: it increases microcirculation in the treated area, stimulates cellular metabolism to enhance the delivery of active ingredients, and mechanically stimulates fibroblasts to boost the production of collagen and elastin.
During the final part of the treatment, electrostimulation is employed using a biphasic rectangular current at a frequency of 2.5 Hz. The stress placed on the nerves by the electrostimulation produces a vasodilatory effect, which enhances microcirculation and, consequently, increases the oxygenation of the treated area. The trichological cap is surrounded by a ring of high-power red (630 nm) and blue (415 nm) LEDs. These LEDs emit non-collimated, monochromatic, coherent light with minimal wavelength variability (+/- 5%), enabling significant biostimulation of fibroblasts and elastin (red light) and providing antibacterial effects (blue light).
The Tricopat has a patented proprietary blend of growth factors and amino acids and protocol which is called Trichogenesi. This product is electrically charged to allow delivery by the Tricopat. Additionally, with the Tricopat we can deliver products such as dutasteride, finasteride, minoxidil, latanoprost, and exoxomes without any local anesthesia or injections. The Tricopat is needle free. The additions of any medications or exosomes to the Tricopat treatment caries a modest increase in the cost of the Tricopat treatment.
The Tricopat Studies
Studies by Antonella Tosti at the University of Miami showed an improvement in hair coverage following four treatments that were three weeks apart. The Tricopat increases anagen duration, forces hair out of the resting phase, and improves hair diameter. The study results are summarized below.
• 60 patients, among the female patients’ group, 15 suffered from AGA, and other 15 suffered from AGA and associated TE. All male patients (30) had AGA. All patients underwent 4 sessions of preformed growth factors vehiculated through iontophoresis at an interval of 3 weeks, over a total period of 12 months. All patients were Caucasian, and the mean age at the diagnosis was 39,9 (range 18-78 years).
• Global photography and trichoscopy revealed the typical aspect of AGA with the presence of diameter variability, peripilar signs and empty follicles in 75% of patients; the fifteen patients with associated TE showed short hairs in regrowth at trichoscopy and a positive pull test with telogen hair roots. All enrolled patients completed the study without adverse reactions or side effects. No pain or discomfort were reported by patients during the procedure and no erosion or breakage of hair shaft was noted on the affected areas.
• Global photography and trichoscopy showed improvement in all 60 patients with a partial or complete reduction in hair loss, confirmed by a negative pull test, associated to the perception of a hair density improvement and a hair shaft diameter thickening. The results are listed in Table 1.
• In particular, male patients showed a 14.61% increase in the total number of hairs/cm2 in the anterior area of the scalp and a 13,62% increase in the hair diameter in the vertex area (Figure 1).
• Female patients, on the other hand, showed a 13.68% increase in the total number of hairs / cm2 at the anterior area and an increase in the hair diameter of 15,61% in the vertex area (Figure 2).
• In all patients a reduction of vellus hair was detected in all areas of the scalp with an increase in the total number of hairs. After 1 year, the researcher’s evaluation reported an evident improvement in all patients: more in detail, a moderate improvement was reported in 6 patients and a significant improvement in 12. All patients were satisfied by the treatment; 17 referred a moderate improvement and 43 reported a significant improvement. Most of them (53/60) defined the treatment as “painless and pleasant”.
Results after 6 months
Conclusion
Collectively, this is an economical solution for hair loss. We look forward to scheduling you for a Tricopat procedure soon. We recommend four treatments separated by 3 weeks.
